New possibilities for the treatment of mild cognitive impairment and prevention of dementia in patients with cerebrovascular disease. Results of the PRIORITET Observation Program
A common tool for detecting mild cognitive impairment (MCI) is the Montreal Cognitive Assessment (MoCA). An extension of the standard MoCA testing – MoCA-Memory Index Score (MoCA-MIS; Memory Index, MI) – allows a deeper study of the mechanisms of MCI formation. We consider the drug Prospecta as an e...
Saved in:
| Main Authors: | E. Y. Solovieva, P. R. Kamchatnov, L. B. Novikova, O. A. Kicherova, N. M. Khasanova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2023-02-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/1955 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Cellex in patients with mild cognitive impairment
by: B. A. Abusueva, et al.
Published: (2019-04-01) -
Detecting cognitive impairment in cerebrovascular disease using gait, dual tasks, and machine learning
by: Vânia Guimarães, et al.
Published: (2025-04-01) -
Resting-state functional magnetic resonance imaging study on cerebrovascular reactivity changes in the precuneus of Alzheimer’s disease and mild cognitive impairment patients
by: Xue Tang, et al.
Published: (2025-01-01) -
GENETIC AND FUNCTIONAL FACTORS IN THE DEVELOPMENT OF COGNITIVE IMPAIRMENT IN HYPERTENSION: A PROSPECTIVE STUDY
by: Yu. V. Zhitkova, et al.
Published: (2016-12-01) -
New aspects of gliatilin’ application for treating of patients with mild cognitive impairment
by: S. M. Moroz, et al.
Published: (2018-07-01)